PHARMA STOCK IN THE NEWS AFTER APPROVAL TO SET UP NEW MANUFACTURING PLANT IN MADHYA PRADESH

Sun Pharma Laboratories Ltd, a unit of

has approved a Rs 3,000 crore investment for a new greenfield formulations manufacturing facility in Madhya Pradesh. This significant expansion by the Mumbai-based drug major aims to bolster its production capabilities. With a market cap of Rs 4,36,585 crore, the company's share price has risen from Rs 1,570 per share to Rs 1,810 per share, gain of 15% in a span of 3 months. The stock is currently trading at a discount of 6% from it's all time high making it a good time to enter the stock.